Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/3KY stock hub

FRA/3KY has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/3KYis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

23.8B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/3KY

In the news

Latest news · FRA/3KY

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E32.3

P25 n/aP50 n/aP75 n/a

Trailing P/E35.2

P25 n/aP50 n/aP75 n/a

ROE17.3

P25 n/aP50 n/aP75 n/a

ROIC117.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/3KY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

218

Groups with data

Currency

CNY

Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	DE
Employees	9,347
Employees Change	324%
Employees Change Percent	3.6
Enterprise value	EUR 20B
Exchange	Frankfurt Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 23.8B
Price	EUR 3.87
Price currency	EUR
Rev Per Employee	195,782.78x
Sic	2834
Symbol	fra/3KY
Website	https://www.hspharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.84%
EV Earnings	29.63x
EV/EBIT	30.73x
EV/EBITDA	28.64x
EV/FCF	25.79x
EV/Sales	11.04x
FCF yield	3.26%
Forward P/E	32.28x
P/B ratio	5.54x
P/E ratio	35.25x
P/S ratio	13.03x
PE Ratio10 Y	31.87x
PE Ratio3 Y	30.69x
PE Ratio5 Y	27.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	35.94%
EBITDA Margin	38.37%
FCF margin	42.47%
Gross margin	89.89%
Gross Profit	EUR 1.6B
Gross Profit Growth	12.76%
Gross Profit Growth Q	29.25%
Gross Profit Growth3 Y	7.05%
Gross Profit Growth5 Y	9.82%
Net Income	EUR 676.5M
Net Income Growth	27.07%
Net Income Growth Q	47.03%
Net Income Growth3 Y	5.63%
Net Income Growth5 Y	16.63%
Pretax Margin	43.59%
Profit Margin	36.97%
Profit Per Employee	EUR 72,374
ROA	9.44
Roa5y	7.07
ROCE	15.21
ROE	17.35
Roe5y	14.67
ROIC	117.6
Roic5y	60.21

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	47.28%
Cagr3y	36.39%
Cagr5y	4.13%
Div CAGR3	31.93%
EPS Growth	26.42
EPS Growth Q	45.76
EPS Growth3 Y	7.02
EPS Growth5 Y	16.39
FCF Growth	75.31%
FCF Growth Q	178.31%
FCF Growth3 Y	12.99%
FCF Growth5 Y	26.97%
OCF Growth	74.46%
OCF Growth Q	165.5%
OCF Growth10 Y	10.92%
OCF Growth3 Y	13.14%
OCF Growth5 Y	26.1%
Revenue Growth	22.57x
Revenue Growth Q	31.96x
Revenue Growth3 Y	7.5x
Revenue Growth5 Y	9.7x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.42
Assets	EUR 4.9B
Cash	EUR 3.8B
Current Assets	EUR 4.4B
Current Liabilities	EUR 548M
Debt	EUR 12.8M
Debt EBITDA	EUR 0.02
Debt Equity	EUR 0
Debt FCF	EUR 0.02
Equity	EUR 4.3B
Interest Coverage	1,708.2
Liabilities	EUR 552.3M
Long Term Assets	EUR 425.4M
Long Term Liabilities	EUR 4.3M
Net Cash	EUR 3.8B
Net Cash By Market Cap	EUR 16.07
Net Cash Growth	35.05%
Net Debt EBITDA	EUR -5.46
Net Debt Equity	EUR -0.89
Net Debt FCF	EUR -4.93
Tangible Book Value	EUR 4.3B
Tangible Book Value Per Share	EUR 0.7

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.09
Inventory Turnover	2.41
Net Working Capital	EUR -43.4M
Quick ratio	7.92
Working Capital	EUR 3.8B
Working Capital Turnover	EUR 0.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.52%
Dividend Growth	-0.27%
Dividend Growth Years	0%
Dividend per share	EUR 0.04
Dividend Years	5
Dividend Yield	1.03%
Ex Div Date	2025-09-22
Last Dividend	EUR 0.03
Payout Ratio	36.22%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	47.24%
200-day SMA	4.01
3Y total return	153.74%
50-day SMA	3.86
50-day SMA vs 200-day SMA	50under200
5Y total return	22.43%
All Time High	4.88
All Time High Change	-20.64%
All Time High Date	2021-01-18
All Time Low	1.11
All Time Low Change	248.92%
All Time Low Date	2023-08-21
ATR	0.1
Ch YTD	-0.69
High	3.87
High52	4.8
High52 Date	2026-01-14
High52ch	-19.31%
Low	3.85
Low52	2.4
Low52 Date	2025-05-12
Low52ch	61.38%
Ma50ch	0.47%
Price vs 200-day SMA	-3.44%
RSI	43.59
RSI Monthly	61.37
RSI Weekly	49.3
Sharpe ratio	1.03x
Sortino ratio	1.66
Total Return	0.52%
Tr YTD	-0.69
Tr1m	-9.08%
Tr1w	-5.26%
Tr3m	-0.69%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 657.7M
Operating Income Growth	21.14
Operating Income Growth Q	72.2
Operating Income Growth3 Y	8.39
Operating Income Growth5 Y	17.49
Operating margin	35.94

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,239,064,072%
Net Borrowing	-2,790,339.6
Shares Insiders	15.24%
Shares Institutions	8.91%
Shares Qo Q	0.82%
Shares Yo Y	0.52%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 759.7M
Average Volume	2.65x
Bv Per Share	0.71
CAPEX	EUR -43.4M
Ch1m	-9.08
Ch1w	-5.26
Ch1y	45.6
Ch3m	-0.69
Ch3y	143.6
Ch5y	15.96
Ch6m	-4.13
Change	-3.87%
Change From Open	0.49
Close	4.03
Days Gap	-4.34
Depreciation Amortization	45,430,205
Earnings Date	2026-05-18
EBIT	EUR 657.7M
EBITDA	EUR 702.1M
EPS	EUR 0.11
F Score	5
FCF	EUR 777.1M
FCF EV Yield	3.88x
Financing CF	189,243,396
Fiscal Year End	December
Founded	1,995
Graham Number	1.31496
Graham Upside	-66.05
Income Tax	EUR 121.2M
Investing CF	-871,203,475
Is Primary Listing	0
Last Earnings Date	2026-03-29
Last Report Date	2025-12-31
Lynch Fair Value	EUR 1.83
Lynch Upside	-52.83
Ma150	4.04
Ma150ch	-4.16%
Ma20	4.11
Ma20ch	-5.77%
Net CF	132,267,510
Next Earnings Date	2026-05-18
Open	3.85
P FCF Ratio	30.68
P OCF Ratio	29.06
Payment Date	2025-10-30
Position In Range	100
Ppne	396,418,494.4
Price Date	2026-05-08
Price EBITDA	EUR 33.96
Ptbv Ratio	5.59
Relative Volume	2,000x
Revenue	1,829,981,641x
SBC By Revenue	0.95x
Share Based Comp	17,445,579
Tax By Revenue	6.62x
Tax Rate	15.19%
Tr6m	-4.13%
Z Score	23.84

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/3KY dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.0%

$0.04 annual per share

Payout ratio

+36.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+0.5%

Next ex-dividend date: 2025-09-22

Performance

FRA/3KY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/3KY?

Insider, institutional, and short-interest positioning.

Institutional ownership

+8.9%

Share of float held by funds and institutions

Insider ownership

+15.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.5%

Negative means the company is buying back shares.

Technical

FRA/3KY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.6

Neutral momentum band

Price vs 200-day MA

-3.4%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.03

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/3KY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/3KY stock rating?

fra/3KY is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/3KY analysis?

The full report lives at /stocks/fra/3KY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/3KY?

The latest report frames fra/3KY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/3KY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.